Advertisement
Australia markets close in 58 minutes
  • ALL ORDS

    8,149.40
    -59.80 (-0.73%)
     
  • ASX 200

    7,913.30
    -58.30 (-0.73%)
     
  • AUD/USD

    0.6665
    -0.0020 (-0.30%)
     
  • OIL

    80.54
    +0.41 (+0.51%)
     
  • GOLD

    2,408.30
    +9.20 (+0.38%)
     
  • Bitcoin AUD

    101,755.45
    +1,166.32 (+1.16%)
     
  • CMC Crypto 200

    1,399.09
    +68.19 (+5.12%)
     
  • AUD/EUR

    0.6122
    -0.0020 (-0.33%)
     
  • AUD/NZD

    1.1118
    +0.0003 (+0.02%)
     
  • NZX 50

    12,352.68
    +27.08 (+0.22%)
     
  • NASDAQ

    19,522.62
    -182.48 (-0.93%)
     
  • FTSE

    8,155.72
    -49.17 (-0.60%)
     
  • Dow Jones

    40,287.53
    -377.47 (-0.93%)
     
  • DAX

    18,171.93
    -182.87 (-1.00%)
     
  • Hang Seng

    17,560.47
    +142.79 (+0.82%)
     
  • NIKKEI 225

    39,620.66
    -443.13 (-1.11%)
     

Gilead Stock Gains. It’s Trying to Get Into the Obesity Drug Game.

Gilead Stock Gains. It’s Trying to Get Into the Obesity Drug Game.

Gilead Sciences stock was climbing Friday on hopes that it would get into the obesity-drug game. GLP-1s, the technical name for the popular obesity drugs, has been one of the biggest drivers of pharmaceutical stocks in recent months. Which may be why Gilead stock has gained 2.8% to $64.55 in afternoon trading Friday after Jefferies released a note late Thursday night.